Jörg Reimann

Title: Jörg Reimann: Innovator in Immunogenic Molecules

Introduction

Jörg Reimann is a notable inventor based in Ulm-Lehr, Germany. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on enhancing immune responses using specific compositions of HBsAg particles.

Latest Patents

Jörg Reimann holds a patent titled "Delivery of immunogenic molecules vis HBsAg particles." This patent describes compositions of HBsAg particles that contain biologically active molecules. These compositions are utilized in stimulating enhanced immune responses. Notably, antigenic peptides contained in HBsAg particles have been found to produce a CTL response, which is not elicited by the peptide alone. The encapsulation of immunostimulating molecules, such as cytokines, significantly enhances the CTL response evoked by the HBsAg particles themselves.

Career Highlights

Throughout his career, Jörg Reimann has worked with various research institutions and companies. One of the prominent organizations he has been associated with is Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His innovative work has contributed to advancements in immunology and vaccine development.

Collaborations

Jörg Reimann has collaborated with notable individuals in his field, including Yechezkel Barenholz and Dvorah Diminsky. These collaborations have further enriched his research and contributed to the success of his innovations.

Conclusion

Jörg Reimann's contributions to the field of immunology through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in immune response stimulation and vaccine development.